Biofabrication Technologies for Tissue and Organ Engineering and Manufacturing
- 1st Edition - December 1, 2026
- Latest edition
- Editors: Lorenzo Moroni, Sang Jin Lee
- Language: English
Biofabrication Technologies for Tissue and Organ Engineering and Manufacturing is the fourth volume in the Regenerative and Transplant Medicine Series. The book offers a range… Read more
Description
Description
Key features
Key features
- Fourth volume in the Regenerative and Transplant Medicine Series, focusing on biofabrication for tissue and organ engineering
- Presents current progress and future prospects on biofabrication technologies for tissue and organ engineering
- Includes regulatory and ethical considerations
Readership
Readership
Table of contents
Table of contents
2. Extrusion-based printing
3. Light-based printing
4. Supporting bath
5. Volumetric printing
6. Multi-nozzle multi-material printing
7. In situ bioprinting
8. 4D printing
9. Bioassembly
10. Bioinks
11. Tissue-specific bioinks
12. Vascular networks
13. Musculoskeletal tissue(s)
14. Heart, cardiac tissue
15. Liver, hepatic tissue
16. Kidney, renal tissue
17. Lung
18. Pancreas
19. Ovary
20. Regulations
21. Industrial perspective, commercialization
Product details
Product details
- Edition: 1
- Latest edition
- Published: December 1, 2026
- Language: English
About the editors
About the editors
LM
Lorenzo Moroni
Prof. Lorenzo Moroni studied Biomedical Engineering at Polytechnic University of Milan, Italy, and Nanoscale Sciences at Chalmers Technical University, Sweden. He received his Ph.D. cum laude in 2006 at University of Twente on 3D scaffolds for cartilage and osteochondral regeneration, for which he was awarded the European doctorate award in Biomaterials and Tissue Engineering from the European Society of Biomaterials. His research group interests aim at developing new biofabrication technologies to generate libraries of 3D scaffolds able to control cell fate. This passes through the design of biomaterials, 3D scaffolds, physicochemical, mechanical, and surface properties to better understand cell-material interactions. From 2010-2013, he was a co-founder and scientific advisor of the biotech company Screvo B.V., which is committed to the production of animal implantable 3D high through-put screening systems. He is currently exploring possibilities to start a new spin-off to bring regenerative medicine products for vascular applications to the clinics.
SL